Search FHIR

FHIR Osiris Implementation Guide
1.1.0 - trial-implementation

This page is part of the OSIRIS FHIR Implementation Guide (v1.1.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Requests

These requests are examples of the potential of this IG. These requests will work on each hospital that has a FHIR endpoint using the osiris data model.

Request Patients with breast cancer (primary or metastatic) with a genetic alteration on TP53.

Requests Patient with breast cancer

Patient?
    gender=female
    &_has:Condition:subject:body-site=C50.9

Request Patients with a genetic alteration on TP53 **

Patient?
    _has:Observation:patient:component-code-value-concept=http://loinc.org|48018-6$http://hl7.org/fhir/uv/genomics-reporting/ValueSet/hgnc|TP53

Final request

Patient?
    gender=female
    &_has:Condition:subject:body-site=C50.9
    &_has:Observation:patient:component-code-value-concept=http://loinc.org|48018-6$http://hl7.org/fhir/uv/genomics-reporting/ValueSet/hgnc|TP53

Request Patients with colorectal cancer and metastatic with an genetic alteration on KRAS, treated by Bevacizumab and progressing.

Request female Patients with a colorectal cancer

Patient?
    gender=female
    &_has:Condition:subject:body-site=C18.9

Request Patients with metastasis

Condition?
    code=C2939419

Request Patients treated by bevacizumab (ATC code L01XC07)

Patient?
    _has:MedicationStatement:subject:code=L01XC07

Request Patients with an genetic alteration on KRAS

Patient?
    _has:Observation:patient:component-code-value-concept=http://loinc.org|48018-6$http://hl7.org/fhir/uv/genomics-reporting/ValueSet/hgnc|KRAS

Request female Patients with a progressing cancer

Patient?
    gender=female
    &_has:Observation:subject:code-value-concept=https://project.eortc.org/recist|PD

Final request

Patient?
    gender=female
    &_has:Condition:subject:body-site=C18.9
    &_has:Condition:subject:code=C2939419
    &_has:MedicationStatement:subject:code=L01XC07
    &_has:Observation:patient:component-code-value-concept=http://loinc.org|48018-6$http://hl7.org/fhir/uv/genomics-reporting/ValueSet/hgnc|KRAS
    &_has:Observation:subject:code-value-concept=https://project.eortc.org/recist|PD